| Literature DB >> 27279688 |
Pechimuthubabu S Shobhanaa1, Neelaiah Siddaraju1, Sree Rekha Jinkala1, Bhawana Ashok Badhe1, Rajesh N Ganesh1.
Abstract
Fine-needle aspiration cytology (FNAC) features of malignant chondroid syringoma (MCS) are rarely documented. Here, we report a case of recurrent MCS, highlighting its interesting clinicopathologic features. Initially, we received cytology and histopathology slides (for review) of a 57-year-old woman who had undergone resection for an occipital MCS and later presented with recurrence. On reviewing the slides, cytology was consistent with recurrent MCS. However, tissue sections showed features of a malignant epithelial tumor with comedonecrosis and sebaceous differentiation owing to which a diagnosis of metastatic adenocarcinoma/malignant adnexal tumor was suggested. Due to an ambiguous histology, a repeat FNA was performed to perform immunocytochemistry (ICC) and oil-red O stains, which confirmed the diagnosis of MCS with sebaceous differentiation. Thus, in a situation where histology was inconclusive due to lack of representative sections, FNAC played a major role in resolving the diagnostic dilemma and facilitating an appropriate clinical management.Entities:
Keywords: Chondroid syringoma; cytology; fine-needle aspiration; malignant; metastasis; satellite nodules
Year: 2016 PMID: 27279688 PMCID: PMC4881401 DOI: 10.4103/0970-9371.177148
Source DB: PubMed Journal: J Cytol ISSN: 0970-9371 Impact factor: 1.000
Figure 1(a) Highly cellular smear showing MCS cells in a classic chondromyxoid background (MGG, ×200) (b) Histology of MCS showing solid areas with comedonecrosis. Inset shows a focus of sebaceous differentiation (H and E, ×400)
Figure 2(a) Discrete and loosely cohesive groups of plasmacytoid myoepithelial cells and characteristic magenta matrix (b) Sebaceous differentiation (c) Fat positivity of neoplastic cells with sebaceous differentiation (Oil-red O, ×200) (d) Tumor giant cells, one of which shows neurtophilic phagocytosis (Pap, ×400) (e) Cells with eccentrically placed nucleus and vacuolated cytoplasm mimicking adenocarcinoma (Pap, ×400) (f) EMA positivity (ICC ×400) and (g) S-100 positivity (ICC ×400)